Compugen at Stifel 2026 Healthcare Conference: pipeline, cash and catalysts
At a glance
- $CGEN today−0.98%last $2.02
- Vs industry peers+0.19 pts6-peer median −1.17% · in step
- Since Nov 10−2.42%from the first trade after the story
- 52-week range41.3% above low$1.43 – $3.24
- Coverage11 this week22 in 30 days · 2.1× its usual pace
- Sector scannerCalmHealth Care
Nothing reported about compugen across key-person, legal, regulatory, security, operational or financial-integrity risk in three weeks of coverage and 30 days of SEC filings.
Ranges are one standard deviation of volatility around the latest close — about 1 week in 3 moves further. Not a forecast or investment advice.
What it means
- What to watch: In healthcare, the calendar is the catalyst: trial readouts, FDA dates and pricing rules drive most of the moves.
- How the stocks are trading: $CGEN -0.98%, $SF -2.19%, $HR -0.83% in the latest session.
- Timing: It came out during market hours, so traders could react the same day, and the session move may reflect that.
Where the stock stands
Compugen ($CGEN) edged down 0.98% to $2.02 in the latest session. Over the past month it is up 2.5%. That leaves it 38% below its 52-week high of $3.24 and 41% above its low of $1.43. It has been a volatile year: the high was 2.3 times the low, so moves this size are not unusual for it. Stifel Financial ($SF) declined 2.19% to $71.00 in the latest session. Over the past month it is up 7.5%. That leaves it 21% below its 52-week high of $89.83 and 8.6% above its low of $65.40. Its range over the year spans 37%, which is moderate.
What the filings say
The company filed a 6-K — the form for material events — on Nov 9, 1 day before this story; it is $CGEN's own account and the first thing to read. Figures are as filed with the SEC; the $CGEN page has the full statements.
How much coverage it is getting
This is one of 22 stories on these companies in Wook's last 30 days of coverage, including 11 this week. Its 30-day average is about 5 a week, so this week is well above its usual pace. Going by their wording, 23% read bullish, 77% neutral and 0% bearish. This one reads neutral too, in line with most of them. Investing.com wrote 12 of the 22 (55%), so the count reflects one outlet's output more than broad attention.
The bigger picture
Healthcare stories turn on approvals, trial data and pricing: one FDA decision or trial readout can swing a single drugmaker hard, while drug-pricing policy moves the whole group at once. Health Care reads calm on Wook's supply-chain scanner today, with no unusual stress in the filings and disclosures it watches.
What to watch next
For the company's side of it, read its latest SEC filings on the $CGEN page. A US company has to report material news on an 8-K, usually within four business days; foreign issuers use a 6-K. Most of the recent coverage comes from one outlet, so check whether another newsroom has confirmed the story or is only repeating it. To run the numbers yourself, ask Wook AI above about $CGEN: its distance from the high, its last report, or how coverage has changed.
Discussion
No one has weighed in yet. Start the discussion on this story.
What happened after this published
Investing.com published this on November 10, 2026. $CGEN has moved -2.42% ($2.07 to $2.02), $SF has moved -3.08% ($73.26 to $71.00) and $HR has moved -0.93% ($19.34 to $19.16). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.
